Qiao He
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Delivery of a ZBP1 agonist enhances radiotherapy-induced antitumour immunity in hepatocellular carcinoma.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 07, 2026
Multimodal Modeling Distinguishes Treatment Response from Overall Survival in Hepatocellular Carcinoma Receiving Combined Interventional and Targeted Immunotherapy.
Journal: Journal of hepatocellular carcinoma
Published: March 30, 2026
Integrated Radiation Therapy With Immune-Chemotherapy for Unresectable Biliary Tract Cancer: An Exploratory Pilot Study.
Journal: International journal of radiation oncology, biology, physics
Published: June 11, 2025
A pathomics-integrated multimodal model to evaluate chemoimmunotherapy efficacy in unresectable intrahepatic cholangiocarcinoma.
Journal: JHEP reports : innovation in hepatology
Published: June 03, 2025
The landscape of gut microbiota in hepatocarcinogenesis: a comprehensive review of pathogenesis and therapeutic interventions.
Journal: International journal of surgery (London, England)
Published: May 21, 2025
Chronic intermittent hypoxia alleviates alcohol-related liver injury via downregulation of hepatic hypoxia-inducible factor-2α.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: April 17, 2025
Systemic therapy plus HAIC versus systemic therapy for hepatocellular carcinoma: a systematic review and meta-analysis.
Journal: International journal of surgery (London, England)
Published: December 12, 2024
Cyanidin-3-O-glucoside alleviates ethanol-induced liver injury by promoting mitophagy in a Gao-binge mouse model of alcohol-associated liver disease.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: November 27, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026